Rectal diazepam: a clinical and EEG study after a single dose in children

Related Experiment Video

Updated: Nov 11, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

E Franzoni, C Carboni, A Lambertini

    Epilepsia
    |February 1, 1983
    PubMed

    Insights

    Rectal diazepam effectively treats pediatric seizures, showing brain activity changes within minutes. This study confirms its clinical efficacy in children requiring anticonvulsant therapy.

    Area of Science:

    • Pediatric Neurology
    • Clinical Pharmacology

    Background:

    • Seizures in children require prompt and effective anticonvulsant treatment.
    • Diazepam is a commonly used anticonvulsant, but its administration route can impact efficacy and onset.
    • Rectal administration offers a potential alternative for rapid drug delivery in pediatric patients.

    Purpose of the Study:

    • To evaluate the onset of action of rectal diazepam in pediatric patients experiencing seizures.
    • To document the electroencephalogram (EEG) changes following rectal diazepam administration.
    • To confirm the clinical efficacy of rectal diazepam as an anticonvulsant in children.

    Main Methods:

    • EEG monitoring was conducted on ten pediatric patients (3 days to 13 years) admitted for seizures.
    • Rectal diazepam (0.5-1 mg/kg) was administered to nine children; one received intravenous diazepam.
    • EEG data was analyzed to determine the time to therapeutic brain effect and observe electrical activity modifications.

    Main Results:

    • Significant EEG changes were observed between 1 and 9.30 minutes after rectal diazepam administration.
    • The appearance of fast EEG activity in one or both hemispheres was noted.
    • EEG findings correlated with the clinical effectiveness of the anticonvulsant treatment.

    Conclusions:

    • Rectal diazepam demonstrates a rapid onset of action in pediatric patients with seizures.
    • EEG monitoring confirms the drug's ability to modify brain electrical activity effectively.
    • The study supports the clinical efficacy and utility of rectal diazepam for seizure management in children.

    More Related Videos

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

    Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

    Published on: September 20, 2024

    Related Concept Videos

    Sedatives and Hypnotics Drugs: Benzodiazepines01:19

    Sedatives and Hypnotics Drugs: Benzodiazepines

    Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
    Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
    Antiepileptic Drugs: Potassium Channel Activators01:20

    Antiepileptic Drugs: Potassium Channel Activators

    Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
    Ezogabine has gained approval as an adjunctive treatment...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...